Search research articles
Contact Us
Filters
Showing results (1-10 of 88) with videos related to
Page
of 9
Sort By:
Plos Medicine
|
November 30, 2016
The Dengue Vaccine Dilemma: Balancing the Individual and Population Risks and Benefits
Jacqueline Deen
The Australasian Journal of Dermatology
|
January 23, 2019
The use of cinacalcet for the treatment of calciphylaxis in patients with chronic kidney disease: A comprehensive review
Jacqueline Deen, Helmut Schaider
The Indian Journal of Medical Research
|
December 10, 2016
The opportunities & challenges in delivering oral cholera vaccines
Jacqueline Deen, David A Sack
The Journal of Infectious Diseases
|
July 17, 2021
Assessment of Vaccine Herd Protection: Lessons Learned From Cholera and Typhoid Vaccine Trials
Jacqueline Deen, John D Clemens
Lancet (London, England)
|
October 29, 2002
The future of dengue vaccines
Scott B Halstead, Jacqueline Deen
Human Vaccines & Immunotherapeutics
|
April 10, 2018
The case for ring vaccinations with special consideration of oral cholera vaccines
Jacqueline Deen, Lorenz von Seidlein
Expert Review of Vaccines
|
September 16, 2022
Vaccine clinical trials in low- and middle-income countries: a brief review of standard, newer and proposed approaches
Jacqueline Deen, John D Clemens
The Lancet. Global Health
|
April 20, 2019
Paracetamol for dengue fever: no benefit and potential harm?
Jacqueline Deen, Lorenz von Seidlein
Tropical Medicine and Infectious Disease
|
April 3, 2021
Licensed and Recommended Inactivated Oral CholeraVaccines: From Development to Innovative Deployment
Jacqueline Deen, John D Clemens
Case Reports in Dermatological Medicine
|
September 27, 2018
Concurrent Diagnoses of Cutaneous Sarcoidosis and Recurrent Metastatic Breast Cancer: More than a Coincidental Occurrence?
Jacqueline Deen, Nick Mellick, Laura Wheller
Page
of 9
Search research articles
Search
Showing results (1-10 of 88) with videos related to
Sort By:
Page
of 9
Plos Medicine
|
November 30, 2016
The Dengue Vaccine Dilemma: Balancing the Individual and Population Risks and Benefits
Jacqueline Deen
The Australasian Journal of Dermatology
|
January 23, 2019
The use of cinacalcet for the treatment of calciphylaxis in patients with chronic kidney disease: A comprehensive review
Jacqueline Deen, Helmut Schaider
The Indian Journal of Medical Research
|
December 10, 2016
The opportunities & challenges in delivering oral cholera vaccines
Jacqueline Deen, David A Sack
The Journal of Infectious Diseases
|
July 17, 2021
Assessment of Vaccine Herd Protection: Lessons Learned From Cholera and Typhoid Vaccine Trials
Jacqueline Deen, John D Clemens
Lancet (London, England)
|
October 29, 2002
The future of dengue vaccines
Scott B Halstead, Jacqueline Deen
Human Vaccines & Immunotherapeutics
|
April 10, 2018
The case for ring vaccinations with special consideration of oral cholera vaccines
Jacqueline Deen, Lorenz von Seidlein
Expert Review of Vaccines
|
September 16, 2022
Vaccine clinical trials in low- and middle-income countries: a brief review of standard, newer and proposed approaches
Jacqueline Deen, John D Clemens
The Lancet. Global Health
|
April 20, 2019
Paracetamol for dengue fever: no benefit and potential harm?
Jacqueline Deen, Lorenz von Seidlein
Tropical Medicine and Infectious Disease
|
April 3, 2021
Licensed and Recommended Inactivated Oral CholeraVaccines: From Development to Innovative Deployment
Jacqueline Deen, John D Clemens
Case Reports in Dermatological Medicine
|
September 27, 2018
Concurrent Diagnoses of Cutaneous Sarcoidosis and Recurrent Metastatic Breast Cancer: More than a Coincidental Occurrence?
Jacqueline Deen, Nick Mellick, Laura Wheller
Page
of 9